Beta-catenin stabilization stalls the transition from double-positive to single-positive stage and predisposes thymocytes to malignant transformation.

Activation of beta-catenin has been causatively linked to the etiology of colon cancer. Conditional stabilization of this molecule in pro-T cells promotes thymocyte development without the requirement for pre-TCR signaling. We show here that activated beta-catenin stalls the developmental transition from the double-positive (DP) to the single-positive (SP) thymocyte stage and predisposes DP thymocytes to transformation. beta-Catenin-induced thymic lymphomas have a leukemic arrest at the early DP stage. Lymphomagenesis requires Rag activity, which peaks at this developmental stage, as well as additional secondary genetic events. A consistent secondary event is the transcriptional up-regulation of c-Myc, whose activity is required for transformation because its conditional ablation abrogates lymphomagenesis. In contrast, the expression of Notch receptors as well as targets is reduced in DP thymocytes with stabilized beta-catenin and remains low in the lymphomas, indicating that Notch activation is not required or selected for in beta-catenin-induced lymphomas. Thus, beta-catenin activation may provide a mechanism for the induction of T-cell-acute lymphoblastic leukemia (T-ALL) that does not depend on Notch activation.

[1]  F. Prósper,et al.  Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. , 2007, Blood.

[2]  Adam A. Margolin,et al.  NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth , 2006, Proceedings of the National Academy of Sciences.

[3]  F. Weerkamp,et al.  Identification of Notch target genes in uncommitted T-cell progenitors: no direct induction of a T-cell specific gene program , 2006, Leukemia.

[4]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[5]  J. Pongrácz,et al.  Overexpression of ICAT highlights a rolefor catenin‐mediated canonical Wnt signalling in early T cell development , 2006, European journal of immunology.

[6]  J. Aster,et al.  c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. , 2006, Genes & development.

[7]  W. Pear,et al.  Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. , 2006, Blood.

[8]  J. V. van Dongen,et al.  Human thymus contains multipotent progenitors with T/B lymphoid, myeloid, and erythroid lineage potential. , 2006, Blood.

[9]  F. Alt,et al.  Activating Notch1 mutations in mouse models of T-ALL. , 2005, Blood.

[10]  F. Gounari,et al.  Loss of adenomatous polyposis coli gene function disrupts thymic development , 2005, Nature Immunology.

[11]  Andrew P. Weng,et al.  Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.

[12]  W. Pear,et al.  Notch and T cell malignancy. , 2004, Seminars in cancer biology.

[13]  Hong Ma,et al.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[15]  Tatjana Marinkovic,et al.  Reversible lymphomagenesis in conditionally c‐MYC expressing mice , 2004, International journal of cancer.

[16]  J. O'neil,et al.  TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. , 2004, Cancer cell.

[17]  T. Kipps,et al.  Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Birchmeier,et al.  Deletion of β-catenin impairs T cell development , 2003, Nature Immunology.

[19]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[20]  H. Clevers,et al.  Wnt signaling in the thymus. , 2003, Current opinion in immunology.

[21]  Barbara Hoffman,et al.  The proto-oncogene c-myc in hematopoietic development and leukemogenesis , 2002, Oncogene.

[22]  H. Clevers,et al.  WNT Signaling and Lymphocyte Development , 2002, Cell.

[23]  E. Lander,et al.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.

[24]  M. Taketo,et al.  Somatic activation of β-catenin bypasses pre-TCR signaling and TCR selection in thymocyte development , 2001, Nature Immunology.

[25]  H. Clevers,et al.  The β-catenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival , 2001, Nature Immunology.

[26]  W. Pear,et al.  Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. , 2001, Immunity.

[27]  H. Macdonald,et al.  Inactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development , 2001, Nature Immunology.

[28]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G P Nolan,et al.  Wnt signaling is required for thymocyte development and activates Tcf‐1 mediated transcription , 2001, European journal of immunology.

[30]  U. Lendahl,et al.  Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.

[31]  M. Bevan,et al.  Notch signaling in T cell development. , 2000, Current opinion in immunology.

[32]  A. Antipova,et al.  Interaction of Dishevelled and XenopusAxin-Related Protein Is Required for Wnt Signal Transduction , 2000, Molecular and Cellular Biology.

[33]  M. Taketo,et al.  Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.

[34]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[35]  Akira Kikuchi,et al.  DIX Domains of Dvl and Axin Are Necessary for Protein Interactions and Their Ability To Regulate β-Catenin Stability , 1999, Molecular and Cellular Biology.

[36]  T. Dale,et al.  Interaction of Axin and Dvl‐2 proteins regulates Dvl‐2‐stimulated TCF‐dependent transcription , 1999, The EMBO journal.

[37]  H C Clevers,et al.  Critical involvement of Tcf-1 in expansion of thymocytes. , 1998, Journal of immunology.

[38]  Hideki Yamamoto,et al.  Axin, a Negative Regulator of the Wnt Signaling Pathway, Directly Interacts with Adenomatous Polyposis Coli and Regulates the Stabilization of β-Catenin* , 1998, The Journal of Biological Chemistry.

[39]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[40]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[41]  T. Jacks,et al.  V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[42]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[43]  A. Berns,et al.  Activation of a novel proto‐oncogene, Frat1, contributes to progression of mouse T‐cell lymphomas , 1997, The EMBO journal.

[44]  D. Kioussis,et al.  T-cell lymphomas in v-Myb transgenic mice. , 1996, Oncogene.

[45]  J. Woodgett,et al.  Wingless inactivates glycogen synthase kinase‐3 via an intracellular signalling pathway which involves a protein kinase C. , 1996, The EMBO journal.

[46]  H. Mcdevitt,et al.  CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. , 1996, Journal of immunology.

[47]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[48]  H. Fehling,et al.  Crucial role of the pre-T-cell receptor α gene in development of ap but not γδ T cells , 1995, Nature.

[49]  A. Rolink,et al.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor , 1994, The Journal of experimental medicine.

[50]  Norbert Perrimon,et al.  dishevelled and armadillo act in the Wingless signalling pathway in Drosophila , 1994, Nature.

[51]  Anton Berns,et al.  Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging , 1991, Cell.

[52]  F. Rosenbauer,et al.  Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.

[53]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. , 2004, Cancer cell.

[54]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .

[55]  W. Birchmeier,et al.  Deletion of beta-catenin impairs T cell development. , 2003, Nature immunology.

[56]  F. Alt,et al.  Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. , 2001, Immunity.

[57]  H Clevers,et al.  The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. , 2001, Nature immunology.

[58]  H. Macdonald,et al.  Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. , 2001, Nature immunology.

[59]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.

[60]  H Clevers,et al.  Redundant regulation of T cell differentiation and TCRalpha gene expression by the transcription factors LEF-1 and TCF-1. , 1998, Immunity.

[61]  R Kemler,et al.  beta-catenin is a target for the ubiquitin-proteasome pathway. , 1997, The EMBO journal.

[62]  H. Fehling,et al.  Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. , 1995, Nature.

[63]  D. Kioussis,et al.  Complex lymphoid and epithelial thymic tumours in Thyl-myc transgenic mice , 1989, Nature.